CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2025	Sep. 30, 2024
Cash flows from operating activities
Net earnings including non-controlling interests	$ 619	$ 1,218
Adjustments to reconcile net earnings to net cash provided by operating activities
Depreciation and amortization	874	854
Asset impairment charges	337	517
Deferred income taxes	(54)	(107)
Equity in earnings of unconsolidated affiliates, net of dividends	125	(151)
Stock compensation expense	93	74
Loss on asset sales / investment revaluation, net	103	9
Other – net	(10)	(73)
Changes in operating assets and liabilities
Segregated investments	113	(257)
Trade receivables	231	476
Inventories	3,165	1,233
Other current assets	(190)	745
Trade payables	(637)	(1,418)
Payables to brokerage customers	1,798	(249)
Accrued expenses and other payables	(802)	(403)
Net cash provided by operating activities	5,765	2,468
Cash flows from investing activities
Capital expenditures	(892)	(1,071)
Net assets of businesses acquired	(108)	(936)
Proceeds from sales of assets	78	31
Purchases of marketable securities	(11)	0
Proceeds from sales of marketable securities	276	0
Other – net	13	(26)
Net cash used in investing activities	(644)	(2,002)
Cash flows from financing activities
Long-term debt payments	(763)	(1)
Net (repayments) borrowings under lines of credit agreements	(1,666)	1,627
Share repurchases, net of tax	0	(2,327)
Cash dividends	(743)	(744)
Acquisition of non-controlling interest	(4)	0
Other – net	(21)	(20)
Net cash used in financing activities	(3,197)	(1,465)
Effect of exchange rate on cash, cash equivalents, restricted cash, and restricted cash equivalents	27	6
Increase (Decrease) in cash, cash equivalents, restricted cash, and restricted cash equivalents	1,951	(993)
Cash, cash equivalents, restricted cash, and restricted cash equivalents - beginning of period	3,924	5,390
Cash, cash equivalents, restricted cash, and restricted cash equivalents - end of period	$ 5,875	$ 4,397